Danaher Corporation $DHR Stock: NFSG Corp Grows Position

by · The Cerbat Gem

NFSG Corp grew its position in Danaher Corporation (NYSE:DHR – Free Report) by 488.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,091 shares of the conglomerate’s stock after purchasing an additional 2,566 shares during the quarter. NFSG Corp’s holdings in Danaher were worth $685,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Veery Capital LLC boosted its holdings in shares of Danaher by 3.1% during the 3rd quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after purchasing an additional 48 shares during the last quarter. Studio Investment Management LLC lifted its position in Danaher by 3.3% in the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after buying an additional 51 shares during the last quarter. JDH Wealth Management LLC grew its holdings in Danaher by 4.5% during the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock valued at $240,000 after purchasing an additional 55 shares during the last quarter. OLD Second National Bank of Aurora grew its stake in shares of Danaher by 0.5% during the first quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate’s stock valued at $2,297,000 after buying an additional 57 shares during the last quarter. Finally, Adelphi Trust Co grew its position in Danaher by 2.5% in the 3rd quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate’s stock valued at $524,000 after acquiring an additional 57 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the subject of a number of research analyst reports. Royal Bank Of Canada lifted their target price on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Stifel Nicolaus cut their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. TD Cowen boosted their price target on Danaher from $236.00 to $255.00 and gave the company a “buy” rating in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Two research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $235.41.

Check Out Our Latest Stock Report on DHR

Danaher Stock Performance

Shares of NYSE:DHR traded down $2.63 during trading on Friday, hitting $228.87. 3,516,366 shares of the stock traded hands, compared to its average volume of 4,667,069. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a fifty day moving average price of $214.04 and a two-hundred day moving average price of $195.97. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a market cap of $160.89 billion, a price-to-earnings ratio of 40.65, a P/E/G ratio of 2.91 and a beta of 0.76.

Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the business earned $0.77 earnings per share. As a group, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).